{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:04:20Z","timestamp":1789664660040,"version":"4.0.1"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Kelch-like protein 11 (KLHL11) encephalitis is a rare clinical condition characterized by autoimmune-mediated encephalitis associated with the presence of KLHL11 antibodies, which commonly presents with ataxia, diplopia, vertigo, hearing loss, and seizures. While the link between this high-risk paraneoplastic autoantibody and male testicular germ cell tumors is well-established, female cases are rare, and no case of ductal breast carcinoma or dual primary malignancies have been reported. The disease is generally resistant to conventional therapies. In this study, we reported a case of KLHL11 encephalitis in a female patient presenting with fever, seizures, and ataxia, alongside dual primary malignancies: ductal breast carcinoma and pulmonary adenocarcinoma. Following immunotherapy with a neonatal Fc receptor (FcRn) inhibitor (efgartigimod) and resection of tumors, the patient achieved complete symptomatic remission with no recurrence. Current studies showed that KLHL11 encephalitis contributed to pathogenesis through cytotoxic T-cell-mediated neuronal injury and loss. However, in this case, rapid clinical improvement was observed after FcRn inhibitor therapy. This is the first report of FcRn inhibitor in the treatment of KLHL11 encephalitis. This case demonstrated a rare association of KLHL11 encephalitis with breast and lung cancer, and expanded on the clinical manifestations, associated tumor types, and treatment options of KLHL11 encephalitis in women.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1613070","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:53:55Z","timestamp":1762433635000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: KLHL11 encephalitis in a female patient with dual primary malignancies of breast and lung cancer: response to FcRn inhibitor therapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Yapeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhentang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1056\/NEJMoa1816721","article-title":"Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis","volume":"381","author":"Mandel-Brehm","year":"2019","journal-title":"New Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2231","article-title":"Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic kelch-like protein-11 encephalitis","volume":"77","author":"Dubey","year":"2020","journal-title":"JAMA Neurology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07843-8","article-title":"Efgartigimod treatment for therapy-refractory autoimmune encephalitis with coexistent NMDAR and LGI1 antibodies: a case report and literature review","volume":"46","author":"Xu","year":"2025","journal-title":"Neurological Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00821-1","article-title":"The therapeutic age of the neonatal Fc receptor","volume":"23","author":"Pyzik","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1273051","article-title":"Anti-Kelch-like protein 11 antibody encephalitis: a case report and literature review","volume":"14","author":"Song","year":"2023","journal-title":"Front Neurology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109074","article-title":"Kelch-like protein 11 antibody-associated paraneoplastic neurological syndrome: A state-of-the-art review","volume":"241","author":"Li","year":"2022","journal-title":"Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000200218","article-title":"Immune checkpoint inhibitor-associated kelch-like protein-11 igG brainstem encephalitis","volume":"11","author":"Aboseif","year":"2024","journal-title":"Neurol Neuroimmunology Neuroinflammation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000209187","article-title":"Pearls & Oy-sters: KLHL11 igG paraneoplastic\u2013associated hearing loss and rhombencephalitis in a woman with metastatic m\u00fcllerian tumor","volume":"102","author":"Agyei","year":"2024","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab185","article-title":"Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis","volume":"3","author":"Vogrig","year":"2021","journal-title":"Brain Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15758","article-title":"Anti-kelchlike protein 11 antibody-associated encephalitis: Two case reports and review of the literature","volume":"30","author":"Le\u00f3n Betancourt","year":"2023","journal-title":"Eur J Neurology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1456840","article-title":"Case report: The case report of ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of KLHL11 encephalitis","volume":"15","author":"Deng","year":"2024","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2023.2269306","article-title":"KLHL11 antibody-associated autoimmune encephalomyelitis in a middle-aged female patient: a case report and literature review","volume":"134","author":"Yang","year":"2023","journal-title":"Int J Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11912-018-0721-y","article-title":"Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes","volume":"20","author":"Grativvol","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12556-1","article-title":"Resolution of anti-LGI1-associated autoimmune encephalitis in a patient after treatment with efgartigimod","volume":"271","author":"Zhu","year":"2024","journal-title":"J Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1444288","article-title":"Case report: Rapid symptom relief in autoimmune encephalitis with efgartigimod: a three-patient case series","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/jci97911","article-title":"Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans","volume":"128","author":"Ulrichts","year":"2018","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1613070\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:53:57Z","timestamp":1762433637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1613070\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":18,"alternative-id":["10.3389\/fimmu.2025.1613070"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1613070","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"article-number":"1613070"}}